W J Van Den Broek
Overview
Explore the profile of W J Van Den Broek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Span P, Sleegers M, Van Den Broek W, Ross H, Nieuwlaat W, Hermus A, et al.
Ann Clin Biochem
. 2003 Jan;
40(Pt 1):94-9.
PMID: 12542917
Background: As recurrences after treatment for differentiated thyroid cancer can occur many years after thyroidectomy, periodic monitoring of serum thyroglobulin (Tg) levels is performed in these patients. However, autoantibodies that...
2.
van Asselt D, Blom H, Zuiderent R, Wevers R, Jakobs C, Van Den Broek W, et al.
Neth J Med
. 2000 Aug;
57(2):41-9.
PMID: 10924940
Background: It is still a commonly held belief that many of the frequently found low cobalamin (Cbl, vitamin B12) levels in older people do not represent deficiency and are therefore...
3.
Oyen W, Verhagen C, Saris E, Van Den Broek W, Pieters G, Corsten F
J Nucl Med
. 2000 Apr;
41(4):643-6.
PMID: 10768565
Unlabelled: For differentiated, nonmedullary thyroid carcinoma, postsurgical ablation of thyroid remnants and treatment of residual tumor and metastases with 131I is a potentially curative therapy. The aim of this study...
4.
Steffens M, Boerman O, de Mulder P, Oyen W, Buijs W, Witjes J, et al.
Clin Cancer Res
. 1999 Oct;
5(10 Suppl):3268s-3274s.
PMID: 10541374
Clinical tumor targeting studies with chimeric monoclonal antibody G250 (cG250) in renal cell carcinoma (RCC) patients indicated the potential use of this antibody for radioimmunotherapy. Here we report on a...
5.
Huysmans D, Buijs W, van de Ven M, Van Den Broek W, KLOPPENBORG P, Hermus A, et al.
J Nucl Med
. 1996 Dec;
37(12):2072-9.
PMID: 8970537
Unlabelled: In patients with a large, multinodular goiter (> 100 g), radiation absorbed doses in the thyroid, surrounding tissues and remainder of the body were estimated after therapeutic administration of...
6.
van Asselt D, Van Den Broek W, Lamers C, Corstens F, Hoefnagels W
J Am Geriatr Soc
. 1996 Aug;
44(8):949-53.
PMID: 8708306
Objective: To study free- and protein-bound cobalamin absorption and the correlation with atrophic gastritis in healthy middle-aged and older subjects. Design: A cross-sectional study. Participants: Fifty-two healthy subjects, aged 26...
7.
van Ree J, Van Den Broek W, Dahlmans V, Wieringa B, Frants R, Havekes L, et al.
Atherosclerosis
. 1995 Nov;
118(1):165-7.
PMID: 8579626
No abstract available.
8.
van Ree J, Van Den Broek W, van der Zee A, Dahlmans V, Wieringa B, Frants R, et al.
Hum Mol Genet
. 1995 Aug;
4(8):1403-9.
PMID: 7581381
The genes encoding apolipoprotein (apo) E and apoC1 are, together with the gene for apoC2, located in a conserved gene cluster on human chromosome 19q12-13.2 and mouse chromosome 7. Although...
9.
Oyen W, Mudde A, Van Den Broek W, Corstens F
J Nucl Med
. 1995 Apr;
36(4):613-5.
PMID: 7699452
Dedifferentiation of well-differentiated thyroid carcinoma is a well-known phenomenon that may lead to the disappearance of radioiodine uptake in tumors and the inability to treat patients with radioiodine. We report...
10.
van Ree J, Hofker M, Van Den Broek W, Van Deursen J, van der Boom H, Frants R, et al.
Biochem J
. 1995 Feb;
305 ( Pt 3):905-11.
PMID: 7848292
The function of apolipoprotein (apo) C1 in vivo is not well understood. From in vitro studies it has been reported that an excess of apoC1 relative to apoE inhibits receptor-mediated...